Phase I clinical results with MLN518, a novel FLT3 antagonist: Tolerability, pharmacokinetics, and pharmacodynamics Meeting Abstract
| Authors: | De Angelo, D. J.; Stone, R. M.; Bruner, R. J.; Caligiuri, M. A.; Heaney, M. L.; Nimer, S. D.; Paquette, R.; Sawyers, C. L.; Lambing, J. L.; Lokker, N. A.; Giese, N. A.; Sinha, V.; Cooper, M. R.; Druker, B. J.; Heinrich, M. C. |
| Abstract Title: | Phase I clinical results with MLN518, a novel FLT3 antagonist: Tolerability, pharmacokinetics, and pharmacodynamics |
| Meeting Title: | 45th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 102 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2003 Dec 6-9 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2003-11-01 |
| Start Page: | 65A |
| End Page: | 66A |
| Language: | English |
| ACCESSION: | WOS:000186536700219 |
| PROVIDER: | wos |
| PUBMED: | 14650391 |
| Notes: | Meeting Abstract: 219 -- 45th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2003 -- SAN DIEGO, CALIFORNIA -- 1 -- Source: Wos |
